Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MX1
Unknown
Unknown
PD184352
MEK
MAPK
10644.146
uM
6.09890
9.03380
-0.6534 -0.6758 2.1767 0.3395
0.9581
0.5967
MX1
Unknown
Unknown
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7523.095
uM
inf
0.22243
0.4987 0.5629 2.6377 0.3218
0.9364
0.8203
MX1
Unknown
Unknown
PS-1145
IKK
NFKB
7523.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0407
-9.0127
0.7668
MX1
Unknown
Unknown
Purvalanol A
CDK1
CDK
7523.067
uM
inf
inf
0.8338 0.8338 0.0000 0.0997
0.0000
0.8380
MX1
Unknown
Unknown
Ro 32-0432
PKC
PKC
10644.142
uM
inf
inf
0.8577 0.8577 0.0000 0.0773
-0.0086
0.5163
MX1
Unknown
Unknown
SB-3CT
MMP2/9
MMP
12220.144
uM
0.21073
1.6780
-0.9996 -1.0000 0.5295 0.7991
0.7647
0.5126
MX1
Unknown
Unknown
SB-3CT
MMP2/9
MMP
10644.144
uM
13.42830
26.81710
-0.8221 -1.0000 1.5883 0.2830
0.9641
0.5357
MX1
Unknown
Unknown
SB-3CT
MMP2/9
MMP
10874.144
uM
16.8960
25.00610
-0.9824 -1.0000 2.8023 0.2025
0.9954
0.7282
MX1
Unknown
Unknown
Selumetinib
MEK
MAPK
12220.155
uM
0.02993
0.55898
-0.6163 -1.0000 0.3753 0.7675
0.9750
0.4858
MX1
Unknown
Unknown
Selumetinib
MEK
MAPK
10874.155
uM
0.39717
0.94112
-0.4198 -0.4296 0.7188 0.4271
0.9765
0.8099
MX1
Unknown
Unknown
Selumetinib
MEK
MAPK
10644.146
uM
0.60435
1.87970
-0.9223 -1.0000 0.9682 0.5608
0.9829
0.5967
MX1
Unknown
Unknown
Sigma A6730
AKT
AKT
10874.153
uM
4.18450
7.94640
-0.9715 -1.0000 1.7130 0.4452
0.9518
0.8467
MX1
Unknown
Unknown
Sigma A6730
AKT
AKT
12220.158
uM
1.68540
3.56750
-0.9998 -1.0000 1.4651 0.4749
0.9683
0.4308
MX1
Unknown
Unknown
Sigma A6730
AKT
AKT
10644.141
uM
3.1030
4.14240
-1.0000 -0.9981 3.7981 0.3955
0.9970
0.4530
MX1
Unknown
Unknown
Sirolimus
MTOR
MTOR
7523.069
uM
1.62940
997.53050
0.1017 -0.9381 0.1646 0.3406
0.6845
0.9585
MX1
Unknown
Unknown
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7523.084
uM
10.90370
54.52310
-0.2511 -0.5904 0.4844 0.4407
0.9634
0.9069
MX1
Unknown
Unknown
Sulindac sulfide
COX1/2
COX
10644.136
uM
46.36640
59.40490
-0.7288 -0.8049 3.8711 0.1583
0.9517
0.5562
MX1
Unknown
Unknown
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7523.067
uM
5.74720
8.93030
-0.9946 -1.0000 2.4926 0.5726
0.9637
0.8380
MX1
Unknown
Unknown
TCS 2312
CHK1
CHK
12220.159
uM
0.20776
0.27858
-0.9963 -0.9811 3.7022 0.7524
0.9910
0.4788
MX1
Unknown
Unknown
TCS 2312
CHK1
CHK
10644.14
uM
0.13263
0.16522
-1.0000 -0.9999 5.0000 0.8599
0.9930
0.4302
MX1
Unknown
Unknown
TCS 2312
CHK1
CHK
10874.152
uM
0.27737
0.39354
-0.9901 -0.9884 3.1183 0.6472
0.9985
0.7706
MX1
Unknown
Unknown
TCS PIM-1 1
Pim kinase
PIM
10644.135
uM
inf
inf
0.0909 0.0909 0.0000 0.3654
0.3187
0.5273
MX1
Unknown
Unknown
TCS PIM-1 1
Pim kinase
PIM
10874.148
uM
inf
inf
0.4360 0.4360 0.0000 0.0768
0.3334
0.6972
MX1
Unknown
Unknown
TCS PIM-1 1
Pim kinase
PIM
12220.135
uM
inf
inf
0.2711 0.2711 0.0000 0.3676
0.4487
0.6564
MX1
Unknown
Unknown
Temsirolimus
MTOR
MTOR
12220.144
uM
0.02360
0.77539
-0.9859 -1.0000 0.3146 0.8616
0.8928
0.5126